SCHEMBL1765144

SCHEMBL1765144

Fc1ccc(C2CCCCN2)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
OPRL1 P41146 2/20 0.40
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
POLB P06746 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C9 P11712 1/20 0.39
KCNH2 Q12809 1/20 0.39
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
HCRTR2 O43614 1/20 0.38
TP53 P04637 1/20 0.37
LTA4H P09960 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30423645 1.00 MEN1 (0.42) MEN1KMT2AOPRL1CYP2D6CYP2C19
SCHEMBL29749243 0.95 MEN1 (0.46) MEN1KMT2AOPRL1CHRNB2CHRNA7
SCHEMBL28840097 0.95 MEN1 (0.46) MEN1KMT2AOPRL1CHRNB2CHRNA7
SCHEMBL28840102 0.95 MEN1 (0.46) MEN1KMT2AOPRL1CHRNB2CHRNA7
SCHEMBL3333995 0.95 MEN1 (0.46) MEN1KMT2AOPRL1CHRNB2CHRNA7
Hydrochloric Acid SCHEMBL28593671 0.93 MEN1 (0.45) MEN1KMT2AOPRL1CHRNB2CHRNA7
Hydrochloric Acid SCHEMBL28593668 0.93 MEN1 (0.45) MEN1KMT2AOPRL1CHRNB2CHRNA7
SCHEMBL1765273 0.86 KDM1A (0.43) MEN1KMT2ACYP2D6CYP2C19POLB
SCHEMBL2707261 0.83 MEN1 (0.43) MEN1KMT2AOPRL1CYP2D6CYP2C19
SCHEMBL31444392 0.83 MEN1 (0.43) MEN1KMT2AOPRL1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504324-B1 SULTAM DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-02-25 EP disclosed
US-8314250-B2 Sultam derivatives HOFFMANN-LA ROCHE INC. (US) 2012-11-20 US disclosed
EP-2504324-A1 SULTAM DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-10-03 EP disclosed
WO-2011064141-A1 SULTAM DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-06-03 WO disclosed
US-20110124686-A1 SULTAM DERIVATIVES ANDERSON KEVIN W 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124686-A1 SULTAM DERIVATIVES SULT1A1, SULT2A1, SULT1E1 MEN1 3823/4885KMT2A 639/4885OPRL1 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.